Status:
COMPLETED
Tailored Messaging for CRC Screening
Lead Sponsor:
University of Pennsylvania
Conditions:
Colorectal Cancer
Eligibility:
All Genders
50-75 years
Phase:
NA
Brief Summary
This is a randomized controlled trial to to determine whether direct, tailored messaging to patients prior to scheduling colonoscopy will increase patient adherence to provider recommendation for scre...
Detailed Description
The proposed study is a prospective, randomized trial. All eligible subjects (patients identified to be contacted to schedule screening colonoscopy) will be randomized to one of three study arms: usua...
Eligibility Criteria
Inclusion
- University of Pennsylvania Health System (UPHS) patients with an active order for screening or surveillance colonoscopy without an existing colonoscopy appointment
- 50-75 years of age
- Due for CRC screening or surveillance (defined as no evidence of: colonoscopy in the past 5 years, fecal immunochemical testing in the past 12 months, flexible sigmoidoscopy or CT colonography in the past 5 years, stool DNA test or Cologuard in the last 3 years)
Exclusion
- Age \<50 or \>75
- Pregnant woman
- Evidence of prior colonoscopy in the past 5 years, fecal immunochemical testing in the past 12 months, flexible sigmoidoscopy or CT colonography in the past 5 years, fecal DNA test or Cologuard in the last 3 years
- History of colorectal cancer
- History of inflammatory bowel disease (Crohn's disease or Ulcerative colitis)
- History of colon surgery or resection
- History of symptoms concerning for colorectal cancer, such as lower GI bleeding, within the past 6 months
- Family history of a hereditary colorectal cancer syndrome, such as familial adenomatous polyposis (FAP) or hereditary non-polyposis colon cancer (HNPCC)
- Current serious medical condition with estimated life expectancy of less than 6 months, such as incurable cancer, end-stage congestive heart failure, decompensated cirrhosis, end stage renal disease, etc.
- Dementia
- Does not speak English
- No telephone number listed in electronic medical record
- Has any other condition that, in the opinion of the investigator, excludes the patient from participating in this study
Key Trial Info
Start Date :
October 9 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2023
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT03310892
Start Date
October 9 2017
End Date
October 1 2023
Last Update
October 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania Health System
Philadelphia, Pennsylvania, United States, 19104